We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

200 hedge funds and large institutions have $8.47B invested in BeOne Medicines Ltd in 2023 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 68 increasing their positions, 70 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more call options, than puts

Call options by funds: $16.8M | Put options by funds: $10.6M

1% more capital invested

Capital invested by funds: $8.4B → $8.47B (+$63.8M)

0.02% more ownership

Funds ownership: 3.77% → 3.78% (+0.02%)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

3% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 70

4% less funds holding

Funds holding: 208 → 200 (-8)

23% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 26

Holders
200
Holders Change
-8
Holders Change %
-3.85%
% of All Funds
3.17%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
20
Increased
68
Reduced
70
Closed
26
Calls
$16.8M
Puts
$10.6M
Net Calls
+$6.15M
Net Calls Change
+$25.3M

Top Buyers

1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$116M
2
Canada Life
Canada Life
Manitoba, Canada
+$54M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$52.4M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$13.7M
5
TD Asset Management
TD Asset Management
Ontario, Canada
+$9.5M

Top Sellers

1
Capital International Investors
Capital International Investors
California
-$48.3M
2
PBA
Paradigm Biocapital Advisors
New York
-$38.5M
3
Bank of America
Bank of America
North Carolina
-$21.9M
4
Invesco
Invesco
Georgia
-$14.1M
5
CII
Capital International Inc
California
-$13.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
DekaBank Deutsche Girozentrale
51
DekaBank Deutsche Girozentrale
Germany
$5.23M +$2.69M +13,600 +85%
Handelsbanken Fonder
52
Handelsbanken Fonder
Sweden
$5M +$79.1K +400 +1%
UBS Group
53
UBS Group
Switzerland
$4.91M -$12.4M -62,877 -70%
AAIS
54
ABN AMRO Investment Solutions
$4.55M +$546K +2,761 +12%
Macquarie Group
55
Macquarie Group
Australia
$4.26M +$499K +2,522 +12%
OCM
56
Ovata Capital Management
Hong Kong
$4.05M +$4.49M +22,701 New
Swedbank
57
Swedbank
Sweden
$3.64M – – –
PAM
58
Pinpoint Asset Management
Hong Kong
$3.61M +$680K +3,436 +84%
Deutsche Bank
59
Deutsche Bank
Germany
$3.53M -$345K -1,743 -8%
OWP
60
Old Well Partners
North Carolina
$3.45M -$297K -1,500 -7%
Asset Management One
61
Asset Management One
Japan
$3.21M – – –
XC
62
XY Capital
Hong Kong
$2.77M +$2.82M +14,235 +1,205%
SAM
63
Storebrand Asset Management
Norway
$2.76M – – –
CGIM
64
Capital Group Investment Management
Singapore
$2.66M – – –
LP
65
LMR Partners
United Kingdom
$2.5M +$2.75M +13,881 New
OAM
66
Oppenheimer Asset Management
New York
$2.48M +$393K +1,986 +17%
CFM
67
Capricorn Fund Managers
United Kingdom
$2.47M +$2.72M +13,735 New
RJA
68
Raymond James & Associates
Florida
$2.35M -$558K -2,821 -18%
EAM
69
Erste Asset Management
Austria
$2.32M – – –
Stifel Financial
70
Stifel Financial
Missouri
$2.3M -$266K -1,344 -9%
IBT
71
International Biotechnology Trust
United Kingdom
$2.28M +$791K +4,000 +46%
American Century Companies
72
American Century Companies
Missouri
$2.21M – – –
JP Morgan Chase
73
JP Morgan Chase
New York
$2.19M -$622K -3,145 -21%
NFGH
74
Nan Fung Group Holdings
Hong Kong
$2.16M – – –
AG
75
AIA Group
Hong Kong
$2.11M +$267K +1,349 +13%
1 2
3
4 5

ONC Hedge Fund Activity: Q3 2023 in Review

200 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q3 2023, worth a combined $8.47B — up 0.76% from $8.4B a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of ONC and 20 opened new positions — a net loss of 6 holders — while 70 trimmed existing stakes and 68 added.

The largest buyer was Baillie Gifford & Co, adding an estimated $116M. The largest seller was Capital International Investors, cutting an estimated $48.3M.

  • 200 institutional investors held BeOne Medicines Ltd (ONC) as of Q3 2023, down from 208 in Q2 2023.
  • Funds reported $8.47B of BeOne Medicines Ltd stock for Q3 2023, up 0.76% quarter-over-quarter.
  • 20 funds opened new BeOne Medicines Ltd positions in Q3 2023 and 26 closed out, a net change of -6 holders.
  • The largest BeOne Medicines Ltd buyer in Q3 2023 was Baillie Gifford & Co, an estimated $116M added.
  • The largest BeOne Medicines Ltd seller in Q3 2023 was Capital International Investors, an estimated $48.3M sold.

Based on aggregated 13F filings for Q3 2023.